Provided by Tiger Fintech (Singapore) Pte. Ltd.

NCI

27.600
+1.1504.35%
Volume:27.31M
Turnover:745.62M
Market Cap:86.10B
PE:9.21
High:27.750
Open:26.900
Low:26.800
Close:26.450
Loading ...

New China Life Insurance - Jan-Sept Accumulated Gross Premium Income RMB145,643.70 Mln

THOMSON REUTERS
·
17 Oct 2024

New China Life Insurance - Accumulated Gross Premium Income Between 1 January and 30 September 2024 Was RMB145,643.70 Mln

THOMSON REUTERS
·
17 Oct 2024

Gain Therapeutics Announces Poster Presentation at 36th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics

GlobeNewswire
·
15 Oct 2024

Aprea Therapeutics Announces Presentations at EORTC-NCI-AACR International Conference on Molecular Targets and Therapeutics

GlobeNewswire
·
10 Oct 2024

Stock Track | NCI Soars 15.93% on Strong Profit Outlook and Buoyant Markets

Stock Track
·
10 Oct 2024

Purple Biotech to Present Data for its Tri-Specific Antibody Platform—CAPTN-3—at the EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics

GlobeNewswire
·
10 Oct 2024

Hong Kong Stocks Rebound Amid Hopes of Further Stimulus; Financial Institutions Surge on $70.7 Billion Swap Facility

MT Newswires Live
·
10 Oct 2024

Hong Kong Stocks Surge; Meituan Rises 5%; Haitong Securities Soars 95%

Market Watcher
·
10 Oct 2024

Avacta to Unveil Pipeline Expansion and Novel, Next-Generational Targeted Cancer Therapy Programs at 2024 EORTC-NCI-AACR Symposium

GlobeNewswire
·
10 Oct 2024

Stock Track | NCI Soars 15.55% on Robust Profit Outlook and Buoyant Markets

Stock Track
·
10 Oct 2024

Hong Kong Stocks up on Thursday; XPeng Jumps 8%

Tiger Newspress
·
10 Oct 2024

Stock Track | NCI Soars as Profit Outlook Shines Amid Economic Recovery

Stock Track
·
10 Oct 2024

Cyclacel Pharmaceuticals to Present New Clinical Data From Phase 2 Study of Oral Fadraciclib at the 2024 EORTC-NCI-AACR Symposium

GlobeNewswire
·
09 Oct 2024

Stock Track | New China Life Soars as Profit Outlook Shines on Economic Recovery

Stock Track
·
09 Oct 2024

Kronos Bio to Present Data at the EORTC-NCI-AACR Symposium that Supports p300 KAT Inhibition in HPV-Driven Tumors

GlobeNewswire
·
09 Oct 2024

Prelude Therapeutics Announces Publication of Abstracts for Presentation at the 36th EORTC-NCI-AACR Symposium

GlobeNewswire
·
09 Oct 2024